In the abstract of an article on Prophylaxis of Prolonged Coma in Insulin Shock by Accornero and Giordani in The Journal, Nov. 23, 1940, page 1835, reference was made to "1-phenol-2-methylaminopropanol." The correct name should have been "1-phenyl-methyl-aminopropane"—a drug apparently marketed in Germany under the name "Pervitin," manufactured by the Temmler-Werke, Vereinigte Chem. Fabriken, Berlin-Johannisthal, Germany. The Council on Pharmacy and Chemistry has found no evidence to show that the drug is available on the American market. Furthermore, under the new Food and Drug Act it would be necessary for the drug to be licensed for sale and interstate commerce. The preparation is related chemically to ephedrine, benzedrine and propadrine.